Skip to main content
Top
Published in: Annals of Hematology 11/2007

01-11-2007 | Original Article

The relationship between iron overload and clinical characteristics in a Spanish cohort of 100 C282Y homozygous hemochromatosis patients

Authors: Albert Altes, Angels Ruiz, Clara Martinez, Anna Esteve, Maria Dolores Vela, Angel Francisco Remacha, Pilar Sarda, Vanessa Bach, Montserrat Baiget

Published in: Annals of Hematology | Issue 11/2007

Login to get access

Abstract

We studied the relationship between iron removed by venesection, sex, age, and clinical characteristics in a group of 100 Spanish probands with hereditary hemochromatosis (HH), all C282Y homozygous in the HFE gene. Iron overload was higher in men than in women (P < 0.0001) and increased with age (P = 0.02). Forty-four patients presented with liver disease (28 had fibrosis–cirrhosis of the liver), 24 with diabetes, 18 with arthropathy, and 13/73 men with impotence. No clinical consequences of hemochromatosis were observed in 43 patients. The number of clinical complications was higher in men (P = 0.01) and increased with age (P = 0.006) and with the amount of iron removed (P < 0.0001). The amount of iron removed was significantly higher by univariate analysis in patients with liver disease (P < 0.0001), diabetes (P = 0.007), arthropathy (P = 0.006), and impotence (P = 0.003) than in patients without these complications. In the multivariant analysis, only liver disease maintained a significant relationship with the amount of iron removed (P < 0.0001). Diabetes and arthropathy were closely related with previous liver disease, and impotence appeared mainly in hemochromatosic men with diabetes and alcoholism.
Literature
1.
go back to reference Adams PC, Deugnier Y, Moirand R, Brissot P (1997) The relationship between iron overload, clinical symptoms, and age in 410 patients with genetic haemochromatosis. Hepatology 25:162–166PubMedCrossRef Adams PC, Deugnier Y, Moirand R, Brissot P (1997) The relationship between iron overload, clinical symptoms, and age in 410 patients with genetic haemochromatosis. Hepatology 25:162–166PubMedCrossRef
2.
go back to reference Adams PC, Reboussin DM, Barton JC et al (2005) Haemochromatosis and iron-overload screening in a racially diverse population. N Engl J Med 352:1769–1778PubMedCrossRef Adams PC, Reboussin DM, Barton JC et al (2005) Haemochromatosis and iron-overload screening in a racially diverse population. N Engl J Med 352:1769–1778PubMedCrossRef
3.
go back to reference Altes A, Ruiz A, Barceló MJ et al (2004) Prevalence of C282Y, H63D and S65C mutations of HFE gene in 1146 newborns from a region of Northern Spain. Genet Test 8:407–410PubMedCrossRef Altes A, Ruiz A, Barceló MJ et al (2004) Prevalence of C282Y, H63D and S65C mutations of HFE gene in 1146 newborns from a region of Northern Spain. Genet Test 8:407–410PubMedCrossRef
4.
go back to reference Barry M, Sherlock SA (1971) Measurements of liver-iron concentration in needle-biopsy specimens. Lancet 1:100–103PubMedCrossRef Barry M, Sherlock SA (1971) Measurements of liver-iron concentration in needle-biopsy specimens. Lancet 1:100–103PubMedCrossRef
5.
go back to reference Beutler E, Felitti VJ, Koziol JA, Ho NJ, Gelbart T (2002) Penetrance of 845→A (C282Y) HFE hereditary haemochromatosis mutations in USA. Lancet 359:211–218PubMedCrossRef Beutler E, Felitti VJ, Koziol JA, Ho NJ, Gelbart T (2002) Penetrance of 845→A (C282Y) HFE hereditary haemochromatosis mutations in USA. Lancet 359:211–218PubMedCrossRef
6.
7.
go back to reference Brissot P, Bourel M, Herry D et al (1981) Assessment of liver iron content in 271 patients: a reevaluation of direct and indirect methods. Gastroenterology 80:557–565PubMed Brissot P, Bourel M, Herry D et al (1981) Assessment of liver iron content in 271 patients: a reevaluation of direct and indirect methods. Gastroenterology 80:557–565PubMed
8.
go back to reference Harrison SA (2006) Liver Disease in patients with diabetes mellitus. J Clin Gastroenterol 40:68–76PubMedCrossRef Harrison SA (2006) Liver Disease in patients with diabetes mellitus. J Clin Gastroenterol 40:68–76PubMedCrossRef
9.
go back to reference Holstein A, Hinze S, Thieben E (2002) Clinical implications of hepatogenous diabetes in liver cirrosis. J Gastroenterol Hepatol 17:677–684PubMedCrossRef Holstein A, Hinze S, Thieben E (2002) Clinical implications of hepatogenous diabetes in liver cirrosis. J Gastroenterol Hepatol 17:677–684PubMedCrossRef
10.
go back to reference Niederau C, Berger M, Stremmel W et al (1984) Hyperinsulinaemia in non-cirrhotic haemochromatosis: impaired hepatic insulin degradation? Diabetología 26:441–444PubMed Niederau C, Berger M, Stremmel W et al (1984) Hyperinsulinaemia in non-cirrhotic haemochromatosis: impaired hepatic insulin degradation? Diabetología 26:441–444PubMed
11.
go back to reference Olsen NS, Nuetzel JA (1950) Resistance to small doses of insulin in various clinical conditions. J Clin Invest 29:862–866PubMed Olsen NS, Nuetzel JA (1950) Resistance to small doses of insulin in various clinical conditions. J Clin Invest 29:862–866PubMed
12.
go back to reference Parke AL, Parke DV (1994) Hepatic disease, the gastrointestinal tract, and rheumatic disease. Curr Opin Rheumatol 6:85–94PubMedCrossRef Parke AL, Parke DV (1994) Hepatic disease, the gastrointestinal tract, and rheumatic disease. Curr Opin Rheumatol 6:85–94PubMedCrossRef
13.
go back to reference Pietrangelo A (2004) Hereditary haemochromatosis—a new look at an old disease. N Engl J Med 350:2383–2397PubMedCrossRef Pietrangelo A (2004) Hereditary haemochromatosis—a new look at an old disease. N Engl J Med 350:2383–2397PubMedCrossRef
14.
go back to reference Strohmeyer G, Niederau C (2000) Diabetes mellitus and haemochromatosis. In: Barton JC, Edwards JC (eds) Haemochromatosis. Cambridge University Press, Cambridge, pp 268–277 Strohmeyer G, Niederau C (2000) Diabetes mellitus and haemochromatosis. In: Barton JC, Edwards JC (eds) Haemochromatosis. Cambridge University Press, Cambridge, pp 268–277
Metadata
Title
The relationship between iron overload and clinical characteristics in a Spanish cohort of 100 C282Y homozygous hemochromatosis patients
Authors
Albert Altes
Angels Ruiz
Clara Martinez
Anna Esteve
Maria Dolores Vela
Angel Francisco Remacha
Pilar Sarda
Vanessa Bach
Montserrat Baiget
Publication date
01-11-2007
Publisher
Springer-Verlag
Published in
Annals of Hematology / Issue 11/2007
Print ISSN: 0939-5555
Electronic ISSN: 1432-0584
DOI
https://doi.org/10.1007/s00277-007-0336-0

Other articles of this Issue 11/2007

Annals of Hematology 11/2007 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.